Can I order Women's Health+ without a consultation?

Yes. Women's Health+ can be purchased online without a referral, clinic registration or mandatory consultation. MediBalans is Genova Diagnostics' exclusive distributor in Sweden.

What does the 6,200 SEK price include?

The direct price includes the Women's Health+ collection kit, Genova laboratory analysis, the laboratory report and one complimentary month of Meet Mario. Medical interpretation, treatment and clinical follow-up are selected separately.

How is the Women's Health+ sample collected?

Women's Health+ uses saliva and urine collected at home according to the timing and preparation instructions supplied with the kit.

Does Women's Health+ diagnose a condition?

No laboratory report establishes PMS, PCOS, endometriosis, perimenopause or another diagnosis by itself. The report provides selected measurements that must be considered with symptoms, history and ordinary medical assessment.

What is the difference between buying the test and becoming a clinic patient?

A direct test order is a standalone product purchase. A MediBalans clinical assessment is a separate healthcare service in which test selection, medical interpretation and any care plan are individualised. You can use either route without buying the other.

Can international patients use the clinic route?

MediBalans offers video appointments in English where appropriate. Test delivery and sample-return availability depend on the destination and should be confirmed before purchase.

Women's Health+ Home Test or Women's Health Clinic

Name: Genova Women's Health+
Brand: Genova Diagnostics
Price: 6200 SEK

Global Constraint Rule

The separate MediBalans
clinical pathway

The clinic route begins with symptoms, history, medicines, previous investigations and ordinary medical or gynaecological care. Selected endocrine, metabolic, gut, nutritional or genetic measurements may be considered when they can answer a defined question.

Global Constraint Rule (GCR) is MediBalans' internal clinical reasoning framework, developed by Dr Mario Anthis, for organising information from several domains and deciding what to investigate first. It is not itself a validated diagnostic test and does not mean that every patient receives every panel.

This assessment, any medical interpretation and any care plan are clinic services. They are not included in the direct Women's Health+ purchase.

GCR · Hormonal Constraint Domains

Four domains the clinic may consider when relevant

01 Gut-related markers. GI Effects® reports beta-glucuronidase among other stool markers. A result does not by itself establish the cause of hormonal symptoms.

02 Genetic context. Panels such as MethylDetox report selected variants, including COMT. A variant is interpreted with clinical context and is not a diagnosis or automatic treatment instruction.

03 Immune and food-reaction questions. If clinically relevant, the clinic may discuss what an ALCAT result can and cannot show before deciding whether it adds useful information.

04 Nutritional measurements. CMA and other panels report selected nutritional markers. Results require interpretation alongside diet, medicines, symptoms and standard laboratory findings.

Separate clinic route

Areas assessed in clinic

Perimenopause & Menopause

Perimenopause is a clinical transition in which cycle pattern and symptoms can change over time. Assessment also considers medicines, contraception or hormone therapy, sleep, mental health and other possible causes of symptoms.

Testing is selected for a defined question: standard clinical assessment remains central. A clinician may sometimes add hormone, metabolite or timed-cortisol measurements, but no specialised panel explains symptom severity by itself.

GCR Review in Perimenopause

The clinic framework considers endocrine, sleep, stress and metabolic information together. No Genova panel is automatically mandatory; selection depends on the individual assessment.

Genova Diagnostics

Women's Health+ / Menopause Plus™

Profiles selected sex hormones, hormone metabolites, cortisol-related measurements and other reported markers. Compare the exact panel and collection schedule before ordering.

Genova Diagnostics

Adrenal Stress Profile

Uses timed saliva samples to report cortisol and DHEA-related measurements across the day. The result does not diagnose the cause of symptoms on its own.

MediBalans

MethylDetox — COMT + CYP1B1

Reports selected genetic variants. Genotype does not establish current hormone status and is considered only when it can add useful clinical context.

MediBalans

CMA — 55 Intracellular Markers

Reports selected micronutrient-related measurements in cultured lymphocytes. Results are interpreted with diet, medication and standard laboratory information.

PCOS — individual assessment

PCOS is diagnosed using accepted clinical criteria and after considering other possible causes. Symptoms, cycle history, androgen-related findings and metabolic risk can differ between people.

Metabolic and endocrine context may be relevant, but a home test does not confirm PCOS or identify a single cause. Standard medical assessment and appropriate follow-up remain important.

GCR Review in PCOS

The clinic may organise relevant endocrine, metabolic, nutritional and lifestyle information using the GCR framework. There is no fixed test sequence for every patient.

Cell Science Systems

ALCAT 250+ — Immune Reactivity

Reports white-cell reactions observed within the assay. It does not diagnose PCOS, insulin resistance or a food allergy, and any dietary use requires clinical context.

Genova Diagnostics

Adrenal Stress Profile

Reports timed salivary cortisol and DHEA-related measurements. It cannot by itself identify ovarian versus adrenal causes of androgen-related symptoms.

Genova Diagnostics

NutrEval® Metabolomics

Reports a broad group of nutritional and metabolism-related markers using blood and first-morning urine. Collection must be coordinated.

MediBalans

MethylDetox — 38 Genes

Reports selected variants, including MTHFR and COMT. Results do not define a supplementation strategy on their own.

Endometriosis & Fibroids

Endometriosis and fibroids require appropriate medical or gynaecological assessment; imaging or other investigations may be needed. Specialised laboratory panels do not diagnose either condition.

Selected hormone, metabolic or gut markers may be discussed as supplementary information in an individual case. An association in research or a laboratory value does not prove that it caused a person's symptoms.

GCR Review in Endometriosis

The clinic framework can organise existing findings and decide whether any additional measurement has a defined purpose. GI Effects® and genetic panels are not blanket prerequisites.

Genova Diagnostics

GI Effects® + Beta-Glucuronidase

GI Effects® reports beta-glucuronidase alongside other stool markers. It does not diagnose endometriosis, fibroids or an oestrogen disorder.

MediBalans

MethylDetox — COMT + CYP1B1

Reports selected genetic variants. Results describe genotype, not current disease, symptom cause or an individual cancer-risk calculation.

Cell Science Systems

ALCAT 250+ — Immune Reactivity

Reports reactions observed within the assay. It cannot identify a food as the cause of endometriosis or pain on its own.

MediBalans

CMA — 55 Intracellular Markers

Reports selected intracellular micronutrient-related measurements. Clinical relevance is assessed case by case.

PMS & PMDD

PMS and PMDD are assessed primarily through symptom pattern, timing across cycles and clinical criteria. Other medical or mental-health conditions can overlap and should be considered.

Laboratory testing is supplementary. Results should not be used to stop or replace prescribed treatment without discussing the decision with the responsible clinician.

GCR Review in PMS

The clinic may consider endocrine, nutritional, medication, sleep and mental-health factors. No single functional panel is a first-line instrument for every patient.

MediBalans

CMA — 55 Intracellular Markers

Reports selected intracellular micronutrient-related measurements, including magnesium and B-vitamin markers. It does not diagnose PMS or menstrual migraine.

Genova Diagnostics

Rhythm Plus™ — Cycle Mapping

Uses scheduled saliva collection across a menstrual cycle to report selected sex-hormone patterns. Follow the exact collection calendar supplied with the kit.

Cell Science Systems

ALCAT — Immune Reactivity

Reports white-cell reactions observed within the assay. It does not establish histamine intolerance or identify a food as the cause of PMS.

MediBalans

MethylDetox — COMT + MAO-A

Reports selected genetic variants. Such results do not provide a permanent biological explanation for PMDD symptoms.

Chronic fatigue
in women

Persistent fatigue has many possible medical, psychological, sleep-related, nutritional and medication-related causes. New, severe or worsening symptoms require ordinary medical assessment; no home panel provides a complete explanation.

The clinic route is hypothesis-led: history and existing results determine whether additional endocrine, metabolic, nutritional or gut measurements could answer a defined question.

GCR Review in Persistent Fatigue

The GCR framework organises possible domains without assuming that one is always primary. ALCAT, NutrEval, Organix and cortisol testing are selected only when clinically justified.

Cell Science Systems

ALCAT 250+ — Immune Reactivity

Reports reactions observed within the assay. It does not identify the cause of persistent fatigue or provide a diet prescription on its own.

MediBalans

CMA — 55 Intracellular Markers

Reports selected intracellular nutrient-related measurements. Findings cannot by themselves explain an energy disorder.

Genova Diagnostics

Adrenal Stress Profile

Reports timed salivary cortisol and DHEA-related measurements. It does not diagnose "adrenal fatigue" or dictate a supplement protocol.

Genova Diagnostics

GI Effects® + SIBO

These panels report selected stool markers or breath-gas curves. They are not mandatory in every fatigue assessment and do not independently establish a cause.

Oestrogen Metabolism

What happens to oestrogen after the ovary

Oestrogens are metabolised through several biochemical pathways. Women's Health+ reports selected parent hormones and metabolites, which is a different measurement scope from a standard serum hormone panel.

No single metabolite ratio, genetic variant or stool marker provides a complete picture of hormonal health, establishes disease risk or determines treatment by itself.

A separate gut marker: GI Effects® reports stool beta-glucuronidase activity. That value does not quantify systemic oestrogen exposure or prove that the gut is causing a person's symptoms.

E2

Oestradiol (E2) — CYP1A1/1B1

Oestradiol can be converted into several hydroxylated metabolites. The report displays selected measurements from these pathways.

2OH

2-OH-Oestrone — reported metabolite

One of the hydroxylated oestrogen metabolites shown in the laboratory report. A result is not a standalone health or disease-risk classification.

Measured in Women's Health+

4OH

4-OH-Oestrone — reported metabolite

Another hydroxylated oestrogen metabolite included in the report. This measurement is not an individual cancer-risk test and does not diagnose endometriosis.

Measured in Women's Health+

16OH

16-OH-Oestrone — reported metabolite

A hydroxylated oestrogen metabolite shown alongside the other reported values. Clinical meaning depends on context and should not be inferred from one value alone.

Measured in Women's Health+

β-G

Beta-Glucuronidase — the oestrobolome

A stool enzyme-activity marker reported by GI Effects®. It is a separate test and does not directly measure blood oestrogen or establish symptom causation.

Reported in GI Effects®

Separate clinic service

How the MediBalans clinical pathway works

This pathway is not included in the Women's Health+ purchase. Tests are selected case by case after clinical assessment; the list below describes possible stages, not a mandatory package.

01

Clinical Consultation

Review of symptoms, history, medicines, prior results and clinical priorities. The GCR framework helps organise which questions, if any, merit further investigation.

Clinical assessmentGCR prioritisation

02

Selected baseline measurements

Standard or specialist tests may be considered if they answer a defined question. ALCAT or CMA is not automatic, and results are interpreted within their stated limitations.

ALCAT 250+CMA 55 markers

03

Endocrine or gut questions

A hormone panel, GI Effects® or another test may be chosen when its sample method and reported markers match the clinical question. No panel establishes causation on its own.

Women's Health+GI Effects®ASP

04

Synthesis and next steps

The clinician reviews relevant findings with symptoms, history and ordinary care. Genetic data may provide context, but it does not define a biological ceiling or treatment plan by itself.

MethylDetox 38 genesCOMT · CYP1B1 · MTHFR

Two distinct services

Choose only the route you want

01

Buy the Genova laboratory test directly

MediBalans is Genova Diagnostics' exclusive distributor in Sweden. Women's Health+ can be ordered without referral, clinic registration or a mandatory appointment.

02

Keep medical interpretation optional

The direct purchase ends with the laboratory report. You can use it yourself, take it to another healthcare provider or book a separate MediBalans results review.

03

Choose the clinic for individual care

If you want clinical test selection or treatment, book the separate clinic route. The GCR framework organises the assessment, but no test or genetic variant automatically dictates care.

Women's Health+ is a laboratory product, not a promise of diagnosis or improvement. The MediBalans clinic is the separate route for an individual medical assessment.

Clear service boundary Test purchase · Optional care

	MediBalans / Women's Health+	GetTested / Female hormone test	Holistic / Female hormone test	Werlabs / Female hormones
Sex hormones (E1, E2, E3, P4, T)	✓	✓ (E2, P4, T, DHEA)	✓ (E2, P4, T, DHEA)	✓ (E2, FSH, LH)
Oestrogen metabolism (2-OH, 4-OH, 16-OH)	✓	—	—	—
Cortisol (diurnal curve)	✓	1 data point	1 data point	—
DHEA	✓	✓	✓	—
Sample type	Saliva + urine	Saliva	Saliva	Blood (serum)
Laboratory	Genova Diagnostics	Verify with provider	Verify with provider	Verify with provider
Medical interpretation	Optional · booked separately	Verify with provider	Verify with provider	Verify with provider
Price	SEK 6,200	Verify with provider	Verify with provider	Verify with provider

Clinical women's healthor Women's Health+at home.

Confirm delivery and care availability first.

The separate MediBalansclinical pathway

Four domains the clinic may consider when relevant

Areas assessed in clinic

Perimenopause & Menopause

Women's Health+ / Menopause Plus™

Adrenal Stress Profile

MethylDetox — COMT + CYP1B1

CMA — 55 Intracellular Markers

PCOS — individual assessment

ALCAT 250+ — Immune Reactivity

Adrenal Stress Profile

NutrEval® Metabolomics

MethylDetox — 38 Genes

Endometriosis & Fibroids

GI Effects® + Beta-Glucuronidase

MethylDetox — COMT + CYP1B1

ALCAT 250+ — Immune Reactivity

CMA — 55 Intracellular Markers

PMS & PMDD

CMA — 55 Intracellular Markers

Rhythm Plus™ — Cycle Mapping

ALCAT — Immune Reactivity

MethylDetox — COMT + MAO-A

Chronic fatiguein women

ALCAT 250+ — Immune Reactivity

CMA — 55 Intracellular Markers

Adrenal Stress Profile

GI Effects® + SIBO

What happens to oestrogen after the ovary

What your results look like

Reported domains in the sample

How the MediBalans clinical pathway works

Choose only the route you want

Buy the Genova laboratory test directly

Keep medical interpretation optional

Choose the clinic for individual care

Questions about hormonal investigation

Compare sample type and reported markers

Buy the test directly.Book care only if you want it.

Explore your Genova report with Meet Mario

Clinical women's health
or Women's Health+
at home.

The separate MediBalans
clinical pathway

Chronic fatigue
in women

Buy the test directly.
Book care only if you want it.